Comments on:

United Therapeutics board OKs new share repurchase

Back to the article » |
SILVER SPRING, Md. (AP) — United Therapeutics Corp. said Monday that its board of directors approved a plan to buy back an additional $420 million of the drug developer's stock. The Silver Spring, Md., company said the program will become effective March 4 and remain open for up to a year. United Therapeutics finished a $100 million share repurchase program by buying nearly 1.2 million shares...

To learn more about commenting on and our community guidelines, please see our comments FAQ.